Does LENALIDOMIDE Cause Product distribution issue? 858 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 858 reports of Product distribution issue have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.3% of all adverse event reports for LENALIDOMIDE.
858
Reports of Product distribution issue with LENALIDOMIDE
0.3%
of all LENALIDOMIDE reports
1
Deaths
35
Hospitalizations
How Dangerous Is Product distribution issue From LENALIDOMIDE?
Of the 858 reports, 1 (0.1%) resulted in death, 35 (4.1%) required hospitalization.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 858 reports have been filed with the FAERS database.
What Other Side Effects Does LENALIDOMIDE Cause?
Diarrhoea (27,576)
Fatigue (22,956)
Death (19,213)
Off label use (17,017)
Rash (15,794)
Pneumonia (14,807)
Plasma cell myeloma (14,191)
Neuropathy peripheral (10,215)
White blood cell count decreased (9,996)
Constipation (9,635)
What Other Drugs Cause Product distribution issue?
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
HUMAN C1-ESTERASE INHIBITOR (107)
Which LENALIDOMIDE Alternatives Have Lower Product distribution issue Risk?
LENALIDOMIDE vs LENIOLISIB
LENALIDOMIDE vs LENOGRASTIM
LENALIDOMIDE vs LENVATINIB
LENALIDOMIDE vs LEPONEX
LENALIDOMIDE vs LERCANIDIPINE